Provided by Tiger Fintech (Singapore) Pte. Ltd.

TherapeuticsMD

1.08
-0.0300-2.70%
Volume:56.61K
Turnover:59.85K
Market Cap:12.50M
PE:-5.71
High:1.15
Open:1.10
Low:1.01
Close:1.11
Loading ...

TherapeuticsMD Inc. Stock Advances 11.4%, Outperforms Market

Dow Jones
·
Yesterday

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Apr

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

TherapeuticsMD Inc. Stock Climbs 13.0%, Outperforms Market

Dow Jones
·
12 Apr

Mayne Pharma Faces Legal Challenge from TherapeuticsMD

TIPRANKS
·
11 Apr

Mayne Pharma Group Served With Legal Proceedings Against US Unit

MT Newswires Live
·
11 Apr

BRIEF-Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract

Reuters
·
09 Apr

TherapeuticsMD Inc - Files Lawsuit Against Mayne Pharma for Breach of Contract - SEC Filing

THOMSON REUTERS
·
09 Apr

TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
09 Apr

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
08 Apr

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
04 Apr

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
02 Apr

TherapeuticsMD Inc. Stock Sheds 5.8%, Underperforms Market

Dow Jones
·
01 Apr

TherapeuticsMD Full Year 2024 Earnings: US$0.20 loss per share (vs US$0.74 loss in FY 2023)

Simply Wall St.
·
29 Mar

TherapeuticsMD Reports Improved Financial Performance

TIPRANKS
·
29 Mar

TherapeuticsMD Reports Reduced Losses and Revenue Growth

TIPRANKS
·
28 Mar

TherapeuticsMD Inc. Stock Rises 4.0%, Outperforms Market

Dow Jones
·
28 Mar

TherapeuticsMD FY24 EPS ($0.20) Up From ($0.74) YoY; Revenue $1.8M Up From $1.3M YoY

Benzinga
·
28 Mar

Press Release: TherapeuticsMD Announces Full Year 2024 Financial Results

Dow Jones
·
28 Mar